Log in or Sign up for Free to view tailored content for your specialty!
Nutrition News
Corrections
In “Nutrition conference speakers stress importance of carotenoids” in the December 2018 issue of Primary Care Optometry News, pages 1 and 15, this sentence should have read: He measured MPOD with the Macular Densitometer (developed by Billy R. Wooten, PhD, from Brown University) and CST by using a rapid assessment variation of the Pelli-Robson chart on an LCD screen, he said.
Nutrition conference speakers stress importance of carotenoids
The importance of macular pigment was a common theme at the Brain and Ocular Nutrition Conference, formerly the Macular Carotenoid Conference, held in Cambridge, England.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Improvement in ocular blood flow may benefit glaucoma patients
SAN ANTONIO – Decreasing the resistance of ocular blood flow around the optic nerve in patients with glaucoma may benefit patients long-term, Nate Lighthizer, OD, said here at the American Academy of Optometry meeting.
Olive oil had no therapeutic effect in DREAM study
To the Editor:
EyePromise appoints new president, CFO
EyePromise announced that it has appointed Andreas Wolf as president and Peggy Stohr as CFO.
MPOD measurement earns CPT code
EyePromise announced that macular pigment optical density measurement by heterochromatic flicker photometry has earned a Category III CPT code from the American Medical Association.
Study shows vitamin improves ocular blood flow
DENVER – Here at Optometry’s Meeting, Ben Gaddie, OD, shared the results of a study that showed that the Optic Nerve Formula (ScienceBased Health) improved ocular blood flow in almost all measures.
Bausch + Lomb introduces chewable eye vitamins
Bausch + Lomb announced the launch of PreserVision AREDS 2 Formula Chewable vitamins.
MacuHealth, MedOp Health settle lawsuit
Executives from MacuHealth and MedOp Health resolved their lawsuit with “a mutual and satisfactory agreement,” according to a press release from MacuHealth.
Neonatal caffeine therapy may improve visuomotor, visual perception outcomes
Neonatal caffeine therapy for apnea of prematurity in very low birth weight infants showed improved visuomotor, visuoperceptual and visuospatial outcomes at age 11 years compared with infants who did not receive the therapy, according to study results published in Pediatrics.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read